Latest news with #LatinAmericanStudies
Yahoo
14-05-2025
- Business
- Yahoo
GT Biopharma Appoints New Member to its Board of Directors
SAN FRANCISCO, CALIFORNIA, May 14, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the 'Company') (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced the appointment of Hilary Kramer to its Board of Directors. Mrs. Kramer will be replacing current board member Bruce Wendel, who is resigning his position. 'We are delighted to welcome Hilary to the Board of Directors at this exciting time, and we look forward to leveraging her expertise as we continue to make great clinical progress with our NK engagers,' said Michael Breen, Executive Chairman and Chief Executive Officer of GT Biopharma. 'Hilary is an experienced executive with a strong strategic and operational background. She is an important addition to the board as the Company evolves in its next phase of maturation as a clinical stage biotech company.' Mrs. Kramer is the Founder and Chief Investment Officer of GreenTech Research, the very first U.S.-based sustainable fund and publisher of growth equity research and global market forecasting. She actively oversees portfolio strategy, positioning, hedging, and fund allocations. Mrs. Kramer has served on the boards of several public companies, including RSL Communications Ltd., Deltathree Inc., El Sitio Inc., and INX Digital, and was a member of the Advisory Boards for DirecTV International and Ibero-American Media Partners. Previously, she was Senior Managing Director and Chief Investment Officer for a $12 billion family office portfolio, where she developed the investment strategy, managed diversified equity and fixed-income portfolios, and directed private equity investments. She has been a consultant at Freddie Mac, Montgomery Asset Management and to families offices. Her earlier career includes investment banking at Lehman Brothers and Morgan Stanley, as well as brand management at General Mills. Mrs. Kramer holds a B.A. with honors in Political Science and Latin American Studies from Wellesley College and an MBA from the Wharton School of the University of Pennsylvania. About GT Biopharma, Inc. GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE® NK cell engager platform. Our TriKE® platform is designed to harness and enhance the cancer killing abilities of a patient's immune system's natural killer cells. GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE® technology. For more information, please visit Forward-Looking Statements Certain statements in this press release may constitute "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in our most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to our filings with the Securities and Exchange Commission. TriKE® is a registered trademark owned by GT Biopharma, Inc. Investor Relations Contact: LifeSci AdvisorsCorey Davis, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Boston Globe
25-04-2025
- General
- Boston Globe
Rhode Island College suspends 20 degree programs, citing low demand
Related : The college is developing 'teach-out plans' for all programs selected for suspension or consolidation, and 'each and every student currently enrolled in those programs will complete their degrees as planned,' Warner wrote. Get Rhode Map A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State. Enter Email Sign Up He added that 'no faculty positions are expected to be impacted,' as the process is intended to reallocate resources 'where they will be most effective.' Advertisement 'This news may come as a surprise to some members of our campus community, and I understand that change of this kind is often a source of trepidation,' Warner wrote. 'I can't emphasize enough that this work should be a regular part of our housekeeping processes; it only seems new and novel because it has not been done for so long.' The suspended programs and concentrations include: 'Art Education BFA, Art Education MA, Art History BA, English MA (Creative Writing), Gender Studies BA, Global Studies BA, Health Sciences- Respiratory Therapy, Health Sciences- Dental Hygiene, and Liberal Studies BA,' according to the college's Advertisement 'Elementary Ed. MED Early Childhood Education; Secondary Ed. BA General Science; Technology Education BS in Teaching; Technology Education BS in Applied Technology,' will also be suspended, along with 'Music Education MED,' world language bachelor of arts degrees in French and Portuguese; and 'modern languages' bachelor of arts degrees in Francophone Studies, French, Latin American Studies, and Portuguese, the report states. Data provided by the college to the Globe shows no students are estimated to complete degrees for 10 of those programs this year, while other programs expect graduates in the single digits, with the highest being the art history program, which has six anticipated degree completions this year. Warner wrote he expects there will be 'some disagreement about the findings in this report' and that administrators will be meeting 'with all the affected program leaders to hear any concerns as we reimagine some programs and reinvigorate others.' 'I believe strongly that higher education institutions need an array of academic degree programs that is dynamic, i.e. those programs with very low demand need to be evaluated for whether they should be continued or make way for new programs with demonstrated high demand,' Warner wrote. Rhode Island College is far from alone in assessing its offerings. Colleges and universities across the United States have been slashing majors and programs – overdue attempts to balance budgets as federal COVID relief funding has dried up, enrollment fluctuates, and operational costs rise, In his letter, Warner wrote the college has been able to stabilize its budget and increase enrollment for the last two years. This year, enrollment topped 6,000 students – a first since 2019, he wrote. Advertisement 'But there is still work to be done,' he added. Christopher Gavin can be reached at
Boston Globe
02-04-2025
- Politics
- Boston Globe
It's not about antisemitism. Trump's zealots want to gut Harvard.
Advertisement 'We must aggressively attack the universities in this country,' Vice President JD Vance said in a 2021 speech titled, in case you had any doubt, Authoritarians always attack the universities. 'In democratic societies, universities are pretty influential centers of dissent,' said Steven Levitsky, a professor of Government and Latin American Studies at Harvard. 'It's difficult to find an autocrat who didn't go after universities.' The Trump administration is pulling, or threatening to pull, billions of dollars in federal grants and contracts from schools in an effort to bring them to heel, and it's generally working: Faced with the prospect of losing $400 million and threats to withhold even more, Advertisement On Monday, They say it's all about combating the bigotry that marred student protests last year over Israel's assaults on Palestinians in Gaza, after Hamas massacred 1,200 Israelis in the heinous attacks of October 2023. As However, that real problem has given MAGA zealots a foothold for wider attacks on academic freedom and vital research, and for targeting Advertisement Elon Musk, the unelected billionaire who is basically running the country, The So far, universities, like other crucial institutions, including There was no indication that he intends to fight Trump's incursions on academic freedom, which infuriates many at the school. So far, about 800 faculty members have signed a letter circulated by Levitsky and a colleague Advertisement 'Garber and others are very smart people,' Levitsky said. 'They know it's a pretext. They know appeasement is not going to work.' Harvard's decision makers are not acting as if democracy is at stake here. If they roll over, they might — might — protect themselves from deeper cuts, but at what cost? Do they really want MAGA telling them what to teach, who to punish, and how to run the university? Besides, over the last year or so, Harvard 'There is no price tag on academic freedom,' Levitsky said. 'If the most prominent members of our civil society — the most influential law firms, the universities, and other civil organizations — if they all retreat to the sidelines ... we will lose our democracy.' This is a time for choosing. If giants like Harvard, Princeton, and Columbia won't join forces and stand up in the courts and on the streets, then less powerful and well-resourced colleges won't stand a chance. Nor will the rest of us. 'Future generations are going to read about this moment,' Levitsky said, 'and they are going to say, 'What the hell were these people thinking? Why didn't they act?'' Maybe the colleges won't win. But are they really going down without a fight? Advertisement Globe columnist Yvonne Abraham can be reached at
